These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The destruction of factor VIII clotting activity by thrombin and plasmin. Denson KW; Redman CW Thromb Res; 1980 May 1-15; 18(3-4):547-9. PubMed ID: 6447928 [No Abstract] [Full Text] [Related]
63. Thrombin mimetic effects of estrogen: II. Gel filtration and centrifugal evidence for estrogen induced polymerization of fibrinogen derivatives. Pilgeram LO; vom dem Bussche G Thromb Res; 1975 Jan; 6(1):19-29. PubMed ID: 163506 [No Abstract] [Full Text] [Related]
64. Enhanced anticlotting activity of fragments D formed during plasmin hydrolysis of fibrinogen in the presence of calcium chloride. Belitser VA; Varetska TV; Tolstykh VM; Tsaryuk LA; Pozdnyakova TM Thromb Res; 1975 Nov; 7(5):797-806. PubMed ID: 128845 [No Abstract] [Full Text] [Related]
65. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates. Song YC; Sheng D; Taubenfeld SM; Matsueda GR Anal Biochem; 1994 Nov; 223(1):88-92. PubMed ID: 7695107 [TBL] [Abstract][Full Text] [Related]
66. [Thrombocyte aggregation in depression and activation of the anticoagulation system of blood in animals]. Pastorova VE Kardiologiia; 1976 Feb; 16(2):123-7. PubMed ID: 135113 [TBL] [Abstract][Full Text] [Related]
67. Physiological inhibition of factor XIII. de Cataldo F; Baudo F Ann N Y Acad Sci; 1972 Dec; 202():341-3. PubMed ID: 4508932 [No Abstract] [Full Text] [Related]
68. Comparative hemostasis: studies on elasmobranchs. Lewis JH Comp Biochem Physiol A Comp Physiol; 1972 May; 42(1):233-40. PubMed ID: 4402712 [No Abstract] [Full Text] [Related]
69. Studies of the coagulation process in the crayfish, Orconectes virilis: attempts to identify a fibrinogen-like factor. Wood PJ; Karpawich PP Comp Biochem Physiol B; 1972 May; 42(1):41-8. PubMed ID: 5075770 [No Abstract] [Full Text] [Related]
70. Selective destruction of the platelet aggregation component in bovine factor VIII preparations by reduction. Brown JE; Baugh R; Hougie C Thromb Res; 1976 Jun; 8(6):777-83. PubMed ID: 960053 [No Abstract] [Full Text] [Related]
71. An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations. Otis PT; Feinstein DI; Rapaport SI; Patch MJ Blood; 1974 Dec; 44(6):771-81. PubMed ID: 4214572 [No Abstract] [Full Text] [Related]
72. Proteolytic fragmentation of fibrinogen. I. Comparison of the fragmentation of human and bovine fibrinogen by trypsin or plasmin. Mihalyi E; Weinberg RM; Towne DW; Friedman ME Biochemistry; 1976 Nov; 15(24):5372-81. PubMed ID: 11813 [No Abstract] [Full Text] [Related]
73. Coagulation factors in human lymph and plasma. Stutman LJ; Dumont AE; Shinowara GY Am J Med Sci; 1965 Sep; 250(3):292-7. PubMed ID: 5829382 [No Abstract] [Full Text] [Related]
74. Hypo or hyper coagulability of blood with high levels of clotting factors. Nour-Eldin R; Lewis FJ Nature; 1966 Oct; 212(5060):417. PubMed ID: 5970163 [No Abstract] [Full Text] [Related]